Global Biopharmaceutical CMO & CRO Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Biopharmaceutical CMO & CRO market size was valued at US$ 19350 million in 2023. With growing demand in downstream market, the Biopharmaceutical CMO & CRO is forecast to a readjusted size of US$ 26390 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Biopharmaceutical CMO & CRO market. Biopharmaceutical CMO & CRO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biopharmaceutical CMO & CRO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biopharmaceutical CMO & CRO market.
A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. A contract research organization (CRO) is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biopharmaceutical CMO & CRO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biopharmaceutical CMO & CRO market. It may include historical data, market segmentation by Type (e.g., Mammalian, Non-mammalian), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biopharmaceutical CMO & CRO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biopharmaceutical CMO & CRO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biopharmaceutical CMO & CRO industry. This include advancements in Biopharmaceutical CMO & CRO technology, Biopharmaceutical CMO & CRO new entrants, Biopharmaceutical CMO & CRO new investment, and other innovations that are shaping the future of Biopharmaceutical CMO & CRO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biopharmaceutical CMO & CRO market. It includes factors influencing customer ' purchasing decisions, preferences for Biopharmaceutical CMO & CRO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biopharmaceutical CMO & CRO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biopharmaceutical CMO & CRO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biopharmaceutical CMO & CRO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biopharmaceutical CMO & CRO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biopharmaceutical CMO & CRO market.
Market Segmentation:
Biopharmaceutical CMO & CRO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Biopharmaceutical CMO & CRO market size was valued at US$ 19350 million in 2023. With growing demand in downstream market, the Biopharmaceutical CMO & CRO is forecast to a readjusted size of US$ 26390 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Biopharmaceutical CMO & CRO market. Biopharmaceutical CMO & CRO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biopharmaceutical CMO & CRO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biopharmaceutical CMO & CRO market.
A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. A contract research organization (CRO) is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biopharmaceutical CMO & CRO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biopharmaceutical CMO & CRO market. It may include historical data, market segmentation by Type (e.g., Mammalian, Non-mammalian), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biopharmaceutical CMO & CRO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biopharmaceutical CMO & CRO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biopharmaceutical CMO & CRO industry. This include advancements in Biopharmaceutical CMO & CRO technology, Biopharmaceutical CMO & CRO new entrants, Biopharmaceutical CMO & CRO new investment, and other innovations that are shaping the future of Biopharmaceutical CMO & CRO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biopharmaceutical CMO & CRO market. It includes factors influencing customer ' purchasing decisions, preferences for Biopharmaceutical CMO & CRO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biopharmaceutical CMO & CRO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biopharmaceutical CMO & CRO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biopharmaceutical CMO & CRO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biopharmaceutical CMO & CRO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biopharmaceutical CMO & CRO market.
Market Segmentation:
Biopharmaceutical CMO & CRO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Mammalian
- Non-mammalian
- Contract Manufacturing
- Contract Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Boehringer Ingelheim GmbH
- Rentschler Biotechnologie GmbH
- Inno Biologics Sdn Bhd
- JRS Pharma
- BIOMEVA GmbH
- ProBioGen
- FUJIFILM Diosynth Biotechnologies USA., Inc.
- TOYOBO CO., LTD
- Samsung BioLogics
- Patheon
- CMC Biologics
- Binex Co., Ltd.
- AbbVie Inc.
- WuXi Biologics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CMO & CRO Market Size 2019-2030
2.1.2 Biopharmaceutical CMO & CRO Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biopharmaceutical CMO & CRO Segment by Type
2.2.1 Mammalian
2.2.2 Non-mammalian
2.3 Biopharmaceutical CMO & CRO Market Size by Type
2.3.1 Biopharmaceutical CMO & CRO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
2.4 Biopharmaceutical CMO & CRO Segment by Application
2.4.1 Contract Manufacturing
2.4.2 Contract Research
2.5 Biopharmaceutical CMO & CRO Market Size by Application
2.5.1 Biopharmaceutical CMO & CRO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
3 BIOPHARMACEUTICAL CMO & CRO MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CMO & CRO Market Size Market Share by Players
3.1.1 Global Biopharmaceutical CMO & CRO Revenue by Players (2019-2024)
3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical CMO & CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CMO & CRO BY REGIONS
4.1 Biopharmaceutical CMO & CRO Market Size by Regions (2019-2024)
4.2 Americas Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
4.3 APAC Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
4.4 Europe Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
4.5 Middle East & Africa Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biopharmaceutical CMO & CRO Market Size by Country (2019-2024)
5.2 Americas Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
5.3 Americas Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CMO & CRO Market Size by Region (2019-2024)
6.2 APAC Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
6.3 APAC Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CMO & CRO by Country (2019-2024)
7.2 Europe Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
7.3 Europe Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CMO & CRO by Region (2019-2024)
8.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
8.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET FORECAST
10.1 Global Biopharmaceutical CMO & CRO Forecast by Regions (2025-2030)
10.1.1 Global Biopharmaceutical CMO & CRO Forecast by Regions (2025-2030)
10.1.2 Americas Biopharmaceutical CMO & CRO Forecast
10.1.3 APAC Biopharmaceutical CMO & CRO Forecast
10.1.4 Europe Biopharmaceutical CMO & CRO Forecast
10.1.5 Middle East & Africa Biopharmaceutical CMO & CRO Forecast
10.2 Americas Biopharmaceutical CMO & CRO Forecast by Country (2025-2030)
10.2.1 United States Biopharmaceutical CMO & CRO Market Forecast
10.2.2 Canada Biopharmaceutical CMO & CRO Market Forecast
10.2.3 Mexico Biopharmaceutical CMO & CRO Market Forecast
10.2.4 Brazil Biopharmaceutical CMO & CRO Market Forecast
10.3 APAC Biopharmaceutical CMO & CRO Forecast by Region (2025-2030)
10.3.1 China Biopharmaceutical CMO & CRO Market Forecast
10.3.2 Japan Biopharmaceutical CMO & CRO Market Forecast
10.3.3 Korea Biopharmaceutical CMO & CRO Market Forecast
10.3.4 Southeast Asia Biopharmaceutical CMO & CRO Market Forecast
10.3.5 India Biopharmaceutical CMO & CRO Market Forecast
10.3.6 Australia Biopharmaceutical CMO & CRO Market Forecast
10.4 Europe Biopharmaceutical CMO & CRO Forecast by Country (2025-2030)
10.4.1 Germany Biopharmaceutical CMO & CRO Market Forecast
10.4.2 France Biopharmaceutical CMO & CRO Market Forecast
10.4.3 UK Biopharmaceutical CMO & CRO Market Forecast
10.4.4 Italy Biopharmaceutical CMO & CRO Market Forecast
10.4.5 Russia Biopharmaceutical CMO & CRO Market Forecast
10.5 Middle East & Africa Biopharmaceutical CMO & CRO Forecast by Region (2025-2030)
10.5.1 Egypt Biopharmaceutical CMO & CRO Market Forecast
10.5.2 South Africa Biopharmaceutical CMO & CRO Market Forecast
10.5.3 Israel Biopharmaceutical CMO & CRO Market Forecast
10.5.4 Turkey Biopharmaceutical CMO & CRO Market Forecast
10.5.5 GCC Countries Biopharmaceutical CMO & CRO Market Forecast
10.6 Global Biopharmaceutical CMO & CRO Forecast by Type (2025-2030)
10.7 Global Biopharmaceutical CMO & CRO Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biopharmaceutical CMO & CRO Product Offered
11.1.3 Lonza Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Information
11.2.2 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Offered
11.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Boehringer Ingelheim GmbH Main Business Overview
11.2.5 Boehringer Ingelheim GmbH Latest Developments
11.3 Rentschler Biotechnologie GmbH
11.3.1 Rentschler Biotechnologie GmbH Company Information
11.3.2 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Offered
11.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Rentschler Biotechnologie GmbH Main Business Overview
11.3.5 Rentschler Biotechnologie GmbH Latest Developments
11.4 Inno Biologics Sdn Bhd
11.4.1 Inno Biologics Sdn Bhd Company Information
11.4.2 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Offered
11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Inno Biologics Sdn Bhd Main Business Overview
11.4.5 Inno Biologics Sdn Bhd Latest Developments
11.5 JRS Pharma
11.5.1 JRS Pharma Company Information
11.5.2 JRS Pharma Biopharmaceutical CMO & CRO Product Offered
11.5.3 JRS Pharma Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 JRS Pharma Main Business Overview
11.5.5 JRS Pharma Latest Developments
11.6 BIOMEVA GmbH
11.6.1 BIOMEVA GmbH Company Information
11.6.2 BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Offered
11.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BIOMEVA GmbH Main Business Overview
11.6.5 BIOMEVA GmbH Latest Developments
11.7 ProBioGen
11.7.1 ProBioGen Company Information
11.7.2 ProBioGen Biopharmaceutical CMO & CRO Product Offered
11.7.3 ProBioGen Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ProBioGen Main Business Overview
11.7.5 ProBioGen Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies USA., Inc.
11.8.1 FUJIFILM Diosynth Biotechnologies USA., Inc. Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 FUJIFILM Diosynth Biotechnologies USA., Inc. Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies USA., Inc. Latest Developments
11.9 TOYOBO CO., LTD
11.9.1 TOYOBO CO., LTD Company Information
11.9.2 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product Offered
11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TOYOBO CO., LTD Main Business Overview
11.9.5 TOYOBO CO., LTD Latest Developments
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Information
11.10.2 Samsung BioLogics Biopharmaceutical CMO & CRO Product Offered
11.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Samsung BioLogics Main Business Overview
11.10.5 Samsung BioLogics Latest Developments
11.11 Patheon
11.11.1 Patheon Company Information
11.11.2 Patheon Biopharmaceutical CMO & CRO Product Offered
11.11.3 Patheon Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Patheon Main Business Overview
11.11.5 Patheon Latest Developments
11.12 CMC Biologics
11.12.1 CMC Biologics Company Information
11.12.2 CMC Biologics Biopharmaceutical CMO & CRO Product Offered
11.12.3 CMC Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 CMC Biologics Main Business Overview
11.12.5 CMC Biologics Latest Developments
11.13 Binex Co., Ltd.
11.13.1 Binex Co., Ltd. Company Information
11.13.2 Binex Co., Ltd. Biopharmaceutical CMO & CRO Product Offered
11.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Binex Co., Ltd. Main Business Overview
11.13.5 Binex Co., Ltd. Latest Developments
11.14 AbbVie Inc.
11.14.1 AbbVie Inc. Company Information
11.14.2 AbbVie Inc. Biopharmaceutical CMO & CRO Product Offered
11.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 AbbVie Inc. Main Business Overview
11.14.5 AbbVie Inc. Latest Developments
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Information
11.15.2 WuXi Biologics Biopharmaceutical CMO & CRO Product Offered
11.15.3 WuXi Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 WuXi Biologics Main Business Overview
11.15.5 WuXi Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CMO & CRO Market Size 2019-2030
2.1.2 Biopharmaceutical CMO & CRO Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biopharmaceutical CMO & CRO Segment by Type
2.2.1 Mammalian
2.2.2 Non-mammalian
2.3 Biopharmaceutical CMO & CRO Market Size by Type
2.3.1 Biopharmaceutical CMO & CRO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
2.4 Biopharmaceutical CMO & CRO Segment by Application
2.4.1 Contract Manufacturing
2.4.2 Contract Research
2.5 Biopharmaceutical CMO & CRO Market Size by Application
2.5.1 Biopharmaceutical CMO & CRO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
3 BIOPHARMACEUTICAL CMO & CRO MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CMO & CRO Market Size Market Share by Players
3.1.1 Global Biopharmaceutical CMO & CRO Revenue by Players (2019-2024)
3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical CMO & CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CMO & CRO BY REGIONS
4.1 Biopharmaceutical CMO & CRO Market Size by Regions (2019-2024)
4.2 Americas Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
4.3 APAC Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
4.4 Europe Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
4.5 Middle East & Africa Biopharmaceutical CMO & CRO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biopharmaceutical CMO & CRO Market Size by Country (2019-2024)
5.2 Americas Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
5.3 Americas Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CMO & CRO Market Size by Region (2019-2024)
6.2 APAC Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
6.3 APAC Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CMO & CRO by Country (2019-2024)
7.2 Europe Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
7.3 Europe Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CMO & CRO by Region (2019-2024)
8.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2019-2024)
8.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET FORECAST
10.1 Global Biopharmaceutical CMO & CRO Forecast by Regions (2025-2030)
10.1.1 Global Biopharmaceutical CMO & CRO Forecast by Regions (2025-2030)
10.1.2 Americas Biopharmaceutical CMO & CRO Forecast
10.1.3 APAC Biopharmaceutical CMO & CRO Forecast
10.1.4 Europe Biopharmaceutical CMO & CRO Forecast
10.1.5 Middle East & Africa Biopharmaceutical CMO & CRO Forecast
10.2 Americas Biopharmaceutical CMO & CRO Forecast by Country (2025-2030)
10.2.1 United States Biopharmaceutical CMO & CRO Market Forecast
10.2.2 Canada Biopharmaceutical CMO & CRO Market Forecast
10.2.3 Mexico Biopharmaceutical CMO & CRO Market Forecast
10.2.4 Brazil Biopharmaceutical CMO & CRO Market Forecast
10.3 APAC Biopharmaceutical CMO & CRO Forecast by Region (2025-2030)
10.3.1 China Biopharmaceutical CMO & CRO Market Forecast
10.3.2 Japan Biopharmaceutical CMO & CRO Market Forecast
10.3.3 Korea Biopharmaceutical CMO & CRO Market Forecast
10.3.4 Southeast Asia Biopharmaceutical CMO & CRO Market Forecast
10.3.5 India Biopharmaceutical CMO & CRO Market Forecast
10.3.6 Australia Biopharmaceutical CMO & CRO Market Forecast
10.4 Europe Biopharmaceutical CMO & CRO Forecast by Country (2025-2030)
10.4.1 Germany Biopharmaceutical CMO & CRO Market Forecast
10.4.2 France Biopharmaceutical CMO & CRO Market Forecast
10.4.3 UK Biopharmaceutical CMO & CRO Market Forecast
10.4.4 Italy Biopharmaceutical CMO & CRO Market Forecast
10.4.5 Russia Biopharmaceutical CMO & CRO Market Forecast
10.5 Middle East & Africa Biopharmaceutical CMO & CRO Forecast by Region (2025-2030)
10.5.1 Egypt Biopharmaceutical CMO & CRO Market Forecast
10.5.2 South Africa Biopharmaceutical CMO & CRO Market Forecast
10.5.3 Israel Biopharmaceutical CMO & CRO Market Forecast
10.5.4 Turkey Biopharmaceutical CMO & CRO Market Forecast
10.5.5 GCC Countries Biopharmaceutical CMO & CRO Market Forecast
10.6 Global Biopharmaceutical CMO & CRO Forecast by Type (2025-2030)
10.7 Global Biopharmaceutical CMO & CRO Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biopharmaceutical CMO & CRO Product Offered
11.1.3 Lonza Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Information
11.2.2 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Offered
11.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Boehringer Ingelheim GmbH Main Business Overview
11.2.5 Boehringer Ingelheim GmbH Latest Developments
11.3 Rentschler Biotechnologie GmbH
11.3.1 Rentschler Biotechnologie GmbH Company Information
11.3.2 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Offered
11.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Rentschler Biotechnologie GmbH Main Business Overview
11.3.5 Rentschler Biotechnologie GmbH Latest Developments
11.4 Inno Biologics Sdn Bhd
11.4.1 Inno Biologics Sdn Bhd Company Information
11.4.2 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Offered
11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Inno Biologics Sdn Bhd Main Business Overview
11.4.5 Inno Biologics Sdn Bhd Latest Developments
11.5 JRS Pharma
11.5.1 JRS Pharma Company Information
11.5.2 JRS Pharma Biopharmaceutical CMO & CRO Product Offered
11.5.3 JRS Pharma Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 JRS Pharma Main Business Overview
11.5.5 JRS Pharma Latest Developments
11.6 BIOMEVA GmbH
11.6.1 BIOMEVA GmbH Company Information
11.6.2 BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Offered
11.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BIOMEVA GmbH Main Business Overview
11.6.5 BIOMEVA GmbH Latest Developments
11.7 ProBioGen
11.7.1 ProBioGen Company Information
11.7.2 ProBioGen Biopharmaceutical CMO & CRO Product Offered
11.7.3 ProBioGen Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ProBioGen Main Business Overview
11.7.5 ProBioGen Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies USA., Inc.
11.8.1 FUJIFILM Diosynth Biotechnologies USA., Inc. Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 FUJIFILM Diosynth Biotechnologies USA., Inc. Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies USA., Inc. Latest Developments
11.9 TOYOBO CO., LTD
11.9.1 TOYOBO CO., LTD Company Information
11.9.2 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product Offered
11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TOYOBO CO., LTD Main Business Overview
11.9.5 TOYOBO CO., LTD Latest Developments
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Information
11.10.2 Samsung BioLogics Biopharmaceutical CMO & CRO Product Offered
11.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Samsung BioLogics Main Business Overview
11.10.5 Samsung BioLogics Latest Developments
11.11 Patheon
11.11.1 Patheon Company Information
11.11.2 Patheon Biopharmaceutical CMO & CRO Product Offered
11.11.3 Patheon Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Patheon Main Business Overview
11.11.5 Patheon Latest Developments
11.12 CMC Biologics
11.12.1 CMC Biologics Company Information
11.12.2 CMC Biologics Biopharmaceutical CMO & CRO Product Offered
11.12.3 CMC Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 CMC Biologics Main Business Overview
11.12.5 CMC Biologics Latest Developments
11.13 Binex Co., Ltd.
11.13.1 Binex Co., Ltd. Company Information
11.13.2 Binex Co., Ltd. Biopharmaceutical CMO & CRO Product Offered
11.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Binex Co., Ltd. Main Business Overview
11.13.5 Binex Co., Ltd. Latest Developments
11.14 AbbVie Inc.
11.14.1 AbbVie Inc. Company Information
11.14.2 AbbVie Inc. Biopharmaceutical CMO & CRO Product Offered
11.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 AbbVie Inc. Main Business Overview
11.14.5 AbbVie Inc. Latest Developments
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Information
11.15.2 WuXi Biologics Biopharmaceutical CMO & CRO Product Offered
11.15.3 WuXi Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 WuXi Biologics Main Business Overview
11.15.5 WuXi Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biopharmaceutical CMO & CRO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Mammalian
Table 3. Major Players of Non-mammalian
Table 4. Biopharmaceutical CMO & CRO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 7. Biopharmaceutical CMO & CRO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 10. Global Biopharmaceutical CMO & CRO Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Biopharmaceutical CMO & CRO Revenue Market Share by Player (2019-2024)
Table 12. Biopharmaceutical CMO & CRO Key Players Head office and Products Offered
Table 13. Biopharmaceutical CMO & CRO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biopharmaceutical CMO & CRO Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Biopharmaceutical CMO & CRO Market Size Market Share by Regions (2019-2024)
Table 18. Global Biopharmaceutical CMO & CRO Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Biopharmaceutical CMO & CRO Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Biopharmaceutical CMO & CRO Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Country (2019-2024)
Table 22. Americas Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 24. Americas Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 26. APAC Biopharmaceutical CMO & CRO Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Region (2019-2024)
Table 28. APAC Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 30. APAC Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 32. Europe Biopharmaceutical CMO & CRO Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Country (2019-2024)
Table 34. Europe Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 36. Europe Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Biopharmaceutical CMO & CRO
Table 45. Key Market Challenges & Risks of Biopharmaceutical CMO & CRO
Table 46. Key Industry Trends of Biopharmaceutical CMO & CRO
Table 47. Global Biopharmaceutical CMO & CRO Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Biopharmaceutical CMO & CRO Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Biopharmaceutical CMO & CRO Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Lonza Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 52. Lonza Biopharmaceutical CMO & CRO Product Offered
Table 53. Lonza Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Lonza Main Business
Table 55. Lonza Latest Developments
Table 56. Boehringer Ingelheim GmbH Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 57. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Offered
Table 58. Boehringer Ingelheim GmbH Main Business
Table 59. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Boehringer Ingelheim GmbH Latest Developments
Table 61. Rentschler Biotechnologie GmbH Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 62. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Offered
Table 63. Rentschler Biotechnologie GmbH Main Business
Table 64. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Rentschler Biotechnologie GmbH Latest Developments
Table 66. Inno Biologics Sdn Bhd Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 67. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Offered
Table 68. Inno Biologics Sdn Bhd Main Business
Table 69. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Inno Biologics Sdn Bhd Latest Developments
Table 71. JRS Pharma Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 72. JRS Pharma Biopharmaceutical CMO & CRO Product Offered
Table 73. JRS Pharma Main Business
Table 74. JRS Pharma Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. JRS Pharma Latest Developments
Table 76. BIOMEVA GmbH Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 77. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Offered
Table 78. BIOMEVA GmbH Main Business
Table 79. BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. BIOMEVA GmbH Latest Developments
Table 81. ProBioGen Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 82. ProBioGen Biopharmaceutical CMO & CRO Product Offered
Table 83. ProBioGen Main Business
Table 84. ProBioGen Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. ProBioGen Latest Developments
Table 86. FUJIFILM Diosynth Biotechnologies USA., Inc. Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 87. FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Product Offered
Table 88. FUJIFILM Diosynth Biotechnologies USA., Inc. Main Business
Table 89. FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. FUJIFILM Diosynth Biotechnologies USA., Inc. Latest Developments
Table 91. TOYOBO CO., LTD Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 92. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product Offered
Table 93. TOYOBO CO., LTD Main Business
Table 94. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. TOYOBO CO., LTD Latest Developments
Table 96. Samsung BioLogics Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 97. Samsung BioLogics Biopharmaceutical CMO & CRO Product Offered
Table 98. Samsung BioLogics Main Business
Table 99. Samsung BioLogics Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Samsung BioLogics Latest Developments
Table 101. Patheon Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 102. Patheon Biopharmaceutical CMO & CRO Product Offered
Table 103. Patheon Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Patheon Main Business
Table 105. Patheon Latest Developments
Table 106. CMC Biologics Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 107. CMC Biologics Biopharmaceutical CMO & CRO Product Offered
Table 108. CMC Biologics Main Business
Table 109. CMC Biologics Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. CMC Biologics Latest Developments
Table 111. Binex Co., Ltd. Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 112. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product Offered
Table 113. Binex Co., Ltd. Main Business
Table 114. Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Binex Co., Ltd. Latest Developments
Table 116. AbbVie Inc. Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 117. AbbVie Inc. Biopharmaceutical CMO & CRO Product Offered
Table 118. AbbVie Inc. Main Business
Table 119. AbbVie Inc. Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. AbbVie Inc. Latest Developments
Table 121. WuXi Biologics Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 122. WuXi Biologics Biopharmaceutical CMO & CRO Product Offered
Table 123. WuXi Biologics Main Business
Table 124. WuXi Biologics Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. WuXi Biologics Latest Developments
Table 1. Biopharmaceutical CMO & CRO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Mammalian
Table 3. Major Players of Non-mammalian
Table 4. Biopharmaceutical CMO & CRO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 7. Biopharmaceutical CMO & CRO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 10. Global Biopharmaceutical CMO & CRO Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Biopharmaceutical CMO & CRO Revenue Market Share by Player (2019-2024)
Table 12. Biopharmaceutical CMO & CRO Key Players Head office and Products Offered
Table 13. Biopharmaceutical CMO & CRO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biopharmaceutical CMO & CRO Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Biopharmaceutical CMO & CRO Market Size Market Share by Regions (2019-2024)
Table 18. Global Biopharmaceutical CMO & CRO Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Biopharmaceutical CMO & CRO Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Biopharmaceutical CMO & CRO Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Country (2019-2024)
Table 22. Americas Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 24. Americas Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 26. APAC Biopharmaceutical CMO & CRO Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Region (2019-2024)
Table 28. APAC Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 30. APAC Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 32. Europe Biopharmaceutical CMO & CRO Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Country (2019-2024)
Table 34. Europe Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 36. Europe Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Biopharmaceutical CMO & CRO
Table 45. Key Market Challenges & Risks of Biopharmaceutical CMO & CRO
Table 46. Key Industry Trends of Biopharmaceutical CMO & CRO
Table 47. Global Biopharmaceutical CMO & CRO Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Biopharmaceutical CMO & CRO Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Biopharmaceutical CMO & CRO Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Lonza Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 52. Lonza Biopharmaceutical CMO & CRO Product Offered
Table 53. Lonza Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Lonza Main Business
Table 55. Lonza Latest Developments
Table 56. Boehringer Ingelheim GmbH Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 57. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Offered
Table 58. Boehringer Ingelheim GmbH Main Business
Table 59. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Boehringer Ingelheim GmbH Latest Developments
Table 61. Rentschler Biotechnologie GmbH Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 62. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Offered
Table 63. Rentschler Biotechnologie GmbH Main Business
Table 64. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Rentschler Biotechnologie GmbH Latest Developments
Table 66. Inno Biologics Sdn Bhd Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 67. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Offered
Table 68. Inno Biologics Sdn Bhd Main Business
Table 69. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Inno Biologics Sdn Bhd Latest Developments
Table 71. JRS Pharma Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 72. JRS Pharma Biopharmaceutical CMO & CRO Product Offered
Table 73. JRS Pharma Main Business
Table 74. JRS Pharma Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. JRS Pharma Latest Developments
Table 76. BIOMEVA GmbH Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 77. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Offered
Table 78. BIOMEVA GmbH Main Business
Table 79. BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. BIOMEVA GmbH Latest Developments
Table 81. ProBioGen Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 82. ProBioGen Biopharmaceutical CMO & CRO Product Offered
Table 83. ProBioGen Main Business
Table 84. ProBioGen Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. ProBioGen Latest Developments
Table 86. FUJIFILM Diosynth Biotechnologies USA., Inc. Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 87. FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Product Offered
Table 88. FUJIFILM Diosynth Biotechnologies USA., Inc. Main Business
Table 89. FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. FUJIFILM Diosynth Biotechnologies USA., Inc. Latest Developments
Table 91. TOYOBO CO., LTD Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 92. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product Offered
Table 93. TOYOBO CO., LTD Main Business
Table 94. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. TOYOBO CO., LTD Latest Developments
Table 96. Samsung BioLogics Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 97. Samsung BioLogics Biopharmaceutical CMO & CRO Product Offered
Table 98. Samsung BioLogics Main Business
Table 99. Samsung BioLogics Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Samsung BioLogics Latest Developments
Table 101. Patheon Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 102. Patheon Biopharmaceutical CMO & CRO Product Offered
Table 103. Patheon Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Patheon Main Business
Table 105. Patheon Latest Developments
Table 106. CMC Biologics Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 107. CMC Biologics Biopharmaceutical CMO & CRO Product Offered
Table 108. CMC Biologics Main Business
Table 109. CMC Biologics Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. CMC Biologics Latest Developments
Table 111. Binex Co., Ltd. Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 112. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product Offered
Table 113. Binex Co., Ltd. Main Business
Table 114. Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Binex Co., Ltd. Latest Developments
Table 116. AbbVie Inc. Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 117. AbbVie Inc. Biopharmaceutical CMO & CRO Product Offered
Table 118. AbbVie Inc. Main Business
Table 119. AbbVie Inc. Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. AbbVie Inc. Latest Developments
Table 121. WuXi Biologics Details, Company Type, Biopharmaceutical CMO & CRO Area Served and Its Competitors
Table 122. WuXi Biologics Biopharmaceutical CMO & CRO Product Offered
Table 123. WuXi Biologics Main Business
Table 124. WuXi Biologics Biopharmaceutical CMO & CRO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. WuXi Biologics Latest Developments
LIST OF FIGURES
Figure 1. Biopharmaceutical CMO & CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CMO & CRO Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biopharmaceutical CMO & CRO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biopharmaceutical CMO & CRO Sales Market Share by Country/Region (2023)
Figure 8. Biopharmaceutical CMO & CRO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2023
Figure 10. Biopharmaceutical CMO & CRO in Contract Manufacturing
Figure 11. Global Biopharmaceutical CMO & CRO Market: Contract Manufacturing (2019-2024) & ($ Millions)
Figure 12. Biopharmaceutical CMO & CRO in Contract Research
Figure 13. Global Biopharmaceutical CMO & CRO Market: Contract Research (2019-2024) & ($ Millions)
Figure 14. Global Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2023
Figure 15. Global Biopharmaceutical CMO & CRO Revenue Market Share by Player in 2023
Figure 16. Global Biopharmaceutical CMO & CRO Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 18. APAC Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 19. Europe Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 21. Americas Biopharmaceutical CMO & CRO Value Market Share by Country in 2023
Figure 22. United States Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Region in 2023
Figure 27. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2023
Figure 28. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2023
Figure 29. China Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Country in 2023
Figure 36. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Figure 37. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Figure 38. Germany Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 52. APAC Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 53. Europe Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 55. United States Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 56. Canada Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 59. China Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 60. Japan Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 61. Korea Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 63. India Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 64. Australia Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 65. Germany Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 66. France Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 67. UK Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 68. Italy Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 69. Russia Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 70. Spain Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 73. Israel Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 76. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biopharmaceutical CMO & CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CMO & CRO Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biopharmaceutical CMO & CRO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biopharmaceutical CMO & CRO Sales Market Share by Country/Region (2023)
Figure 8. Biopharmaceutical CMO & CRO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2023
Figure 10. Biopharmaceutical CMO & CRO in Contract Manufacturing
Figure 11. Global Biopharmaceutical CMO & CRO Market: Contract Manufacturing (2019-2024) & ($ Millions)
Figure 12. Biopharmaceutical CMO & CRO in Contract Research
Figure 13. Global Biopharmaceutical CMO & CRO Market: Contract Research (2019-2024) & ($ Millions)
Figure 14. Global Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2023
Figure 15. Global Biopharmaceutical CMO & CRO Revenue Market Share by Player in 2023
Figure 16. Global Biopharmaceutical CMO & CRO Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 18. APAC Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 19. Europe Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Biopharmaceutical CMO & CRO Market Size 2019-2024 ($ Millions)
Figure 21. Americas Biopharmaceutical CMO & CRO Value Market Share by Country in 2023
Figure 22. United States Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Region in 2023
Figure 27. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2023
Figure 28. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2023
Figure 29. China Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Country in 2023
Figure 36. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Figure 37. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Figure 38. Germany Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Biopharmaceutical CMO & CRO Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 52. APAC Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 53. Europe Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 55. United States Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 56. Canada Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 59. China Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 60. Japan Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 61. Korea Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 63. India Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 64. Australia Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 65. Germany Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 66. France Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 67. UK Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 68. Italy Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 69. Russia Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 70. Spain Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 73. Israel Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Biopharmaceutical CMO & CRO Market Size 2025-2030 ($ Millions)
Figure 76. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Follitropin Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
115 pages
Global Electroretinography Market Growth 2025-2031
US$ 3,660.00
December 2024
99 pages
Global Washer-Disinfector-Dryers Market Growth 2024-2030
US$ 3,660.00
December 2024
113 pages
Global Peripheral Vascular Devices and Accessories Market Growth 2024-2030
US$ 3,660.00
March 2024
112 pages
